A detailed history of Uma Financial Services, Inc. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Uma Financial Services, Inc. holds 87 shares of PCVX stock, worth $4,205. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87
Previous 61 42.62%
Holding current value
$4,205
Previous $1,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$29.67 - $37.37 $771 - $971
26 Added 42.62%
87 $3,000
Q2 2025

Jul 11, 2025

BUY
$28.04 - $37.2 $1,317 - $1,748
47 Added 335.71%
61 $1,000
Q1 2025

Apr 28, 2025

BUY
$37.76 - $92.13 $528 - $1,289
14 New
14 $0

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $2.87B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Uma Financial Services, Inc. Portfolio

Follow Uma Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uma Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Uma Financial Services, Inc. with notifications on news.